MarketCap
Facebook
X
TelegramAnnual report 2022
added 12-23-2023
HEXO Corp. ROE Ratio 2011-2026 | HEXO
Annual ROE Ratio HEXO Corp.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -98.17 | -8.96 | -7.23 | -38.33 | -43.08 | - | - | - | - | - |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -7.23 | -98.17 | -39.15 |
ROE Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aerie Pharmaceuticals
AERI
|
431.6 | - | - | $ 754 M |  USA |
 |
AcelRx Pharmaceuticals
ACRX
|
-162.53 | - | 7.5 % | $ 6.35 M | USA |
 |
Catalent
CTLT
|
-28.94 | - | - | $ 11.5 B | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3276.74 | - | 0.86 % | $ 117 M | USA |
 |
Canopy Growth Corporation
CGC
|
-122.76 | $ 1.07 | -0.47 % | $ 115 M |  Canada |
 |
DURECT Corporation
DRRX
|
-186.86 | - | - | $ 50.1 M | USA |
 |
Endo International plc
ENDP
|
37.13 | - | - | $ 28.9 M |  Irlanda |
 |
Agile Therapeutics
AGRX
|
88.64 | - | 10.11 % | $ 58.2 M | USA |
 |
Evoke Pharma
EVOK
|
302.08 | - | - | $ 36.6 M | USA |
 |
Alimera Sciences
ALIM
|
-43.6 | - | - | $ 142 M | USA |
 |
Harrow Health
HROW
|
-9.8 | $ 38.95 | -27.32 % | $ 1.43 B | USA |
 |
Cronos Group
CRON
|
-4.28 | $ 2.62 | -0.57 % | $ 1.36 B | Canada |
 |
Avadel Pharmaceuticals plc
AVDL
|
-66.13 | - | - | $ 2.06 B |  France |
 |
Jupiter Wellness
JUPW
|
2273.74 | - | - | $ 33.6 M | USA |
 |
China Pharma Holdings
CPHI
|
-61.13 | $ 0.55 | -0.97 % | $ 9.61 M |  China |
 |
Cumberland Pharmaceuticals
CPIX
|
-8.33 | $ 4.5 | -7.02 % | $ 63.3 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-50.54 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
Neoleukin Therapeutics
NLTX
|
7.34 | - | - | $ 193 M | Canada |
 |
Aurora Cannabis
ACB
|
-154.42 | $ 3.52 | -5.26 % | $ 86.3 M | Canada |
 |
Athenex
ATNX
|
1589.72 | - | -23.39 % | $ 1.76 M | USA |
 |
Organogenesis Holdings
ORGO
|
0.33 | $ 2.86 | -4.67 % | $ 377 M | USA |
 |
Emergent BioSolutions
EBS
|
-117.13 | $ 8.87 | -1.33 % | $ 454 M | USA |
 |
ProPhase Labs
PRPH
|
29.02 | - | - | $ 5.07 M | USA |
 |
Assertio Holdings
ASRT
|
-240.53 | $ 11.92 | 1.24 % | $ 847 M | USA |
 |
Radius Health
RDUS
|
27.81 | - | - | $ 1.42 B | USA |
 |
Rockwell Medical
RMTI
|
-39.64 | $ 0.9 | 0.37 % | $ 21 M | USA |
 |
Evolus
EOLS
|
223.5 | $ 4.21 | -1.86 % | $ 261 M | USA |
 |
Bausch Health Companies
BHC
|
57.93 | $ 5.77 | -3.11 % | $ 2.11 B | Canada |
 |
Lannett Company
LCI
|
92.26 | - | 1.15 % | $ 7.11 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
15.26 | - | -39.89 % | $ 27.7 M | USA |
 |
OrganiGram Holdings
OGI
|
-45.46 | $ 1.38 | -3.17 % | $ 402 M | Canada |
 |
Perrigo Company plc
PRGO
|
-48.56 | $ 11.38 | -7.97 % | $ 1.58 B | USA |
 |
Sundial Growers
SNDL
|
-88.87 | $ 1.53 | 0.33 % | $ 3.37 M | Canada |
 |
Pacira BioSciences
PCRX
|
-12.79 | $ 22.06 | 3.67 % | $ 1.02 B | USA |
 |
PetIQ
PETQ
|
0.96 | - | 1.64 % | $ 400 M | USA |
 |
OptiNose
OPTN
|
40.97 | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
-129.32 | - | -27.8 % | $ 2.56 M | USA |
 |
Recro Pharma
REPH
|
-22.63 | - | -4.76 % | $ 65.3 M | USA |
 |
Relmada Therapeutics
RLMD
|
-115.74 | $ 4.67 | -3.51 % | $ 141 M | USA |
 |
SCYNEXIS
SCYX
|
91.88 | $ 0.73 | -2.19 % | $ 34.9 M | USA |
 |
Solid Biosciences
SLDB
|
-90.86 | $ 5.99 | -3.47 % | $ 244 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-78.37 | $ 2.76 | -2.66 % | $ 3.43 M | USA |
 |
Tricida
TCDA
|
-80993.58 | - | - | $ 3.25 M | USA |
 |
TherapeuticsMD
TXMD
|
-35.09 | $ 2.26 | 1.0 % | $ 23.6 M | USA |
 |
Tilray
TLRY
|
-43.81 | $ 7.37 | -2.97 % | $ 4.55 B | Canada |
 |
Veru
VERU
|
-116.97 | $ 2.54 | -3.05 % | $ 343 M | USA |
 |
Viatris
VTRS
|
0.27 | $ 15.09 | -3.89 % | $ 18.1 B | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-75.79 | - | - | $ 55.5 M | USA |
 |
cbdMD
YCBD
|
-7.78 | $ 0.79 | -2.48 % | $ 3.41 M | USA |